Erez Aminov - 02 Aug 2023 Form 3 Insider Report for MIRA PHARMACEUTICALS, INC. (MIRA)

Role
Chief Executive Officer, Director
Signature
/s/ Michelle Yanez, Attorney-in-Fact for Erez Aminov
Issuer symbol
MIRA
Transactions as of
02 Aug 2023
Net transactions value
$0
Form type
3
Filing time
02 Aug 2023, 17:49:16 UTC
Next filing
21 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MIRA Common Stock 373,500 02 Aug 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MIRA Stock Option (right to buy) 02 Aug 2023 Common Stock 150,000 $5.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vested and became exercisable as to 50,000 shares on April 28, 2023, and becomes exercisable as to 50,000 shares on April 28, 2024, and 50,000 shares on April 28, 2025.